Abvc Biopharma (ABVC) EBITDA Margin (2009 - 2026)
Abvc Biopharma's EBITDA Margin came in at -1748.94% for Q2 2026.
Powered by 
Analysis
Abvc Biopharma (ABVC) EBITDA Margin (2009 - 2026) Analysis & Trends
For FY2025, Abvc Biopharma's EBITDA Margin was -22423.39%, down 21506.33 percentage points from FY2024.
- EBITDA Margin carries a five-year change of -20670.21 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -917.06% in FY2024 (+3503.47 pp), -4420.52% in FY2023 (-2864.44 pp), -1556.08% in FY2022 (+1730.62 pp) and -3286.70% in FY2021 (-1533.52 pp).
- The Q2 2026 figure represents the highest quarterly EBITDA Margin since Q3 2024.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2024 (a gain of 35074.22 percentage points), and the weakest in Q1 2024 (a drop of 233952.13 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 42.49% |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,748.94% |
| Dec 31, 2024 | -35,307.43% |
| Sep 30, 2024 | -70.31% |
| Jun 30, 2024 | -722.89% |
| Mar 31, 2024 | -235,433.11% |
| Dec 31, 2023 | -23,291.13% |
| Sep 30, 2023 | -13,519.35% |
| Jun 30, 2023 | -35,797.10% |
| Mar 31, 2023 | -1,480.99% |
| Dec 31, 2022 | -530.83% |
| Sep 30, 2022 | -8,775.65% |
| Jun 30, 2022 | -652.49% |
| Mar 31, 2022 | -24,213.99% |
| Sep 30, 2021 | -1,987.59% |
| Jun 30, 2021 | -6,464.72% |
| Mar 31, 2021 | -474.94% |
| Dec 31, 2020 | -7,788.35% |
| Sep 30, 2020 | -1,108.61% |
| Jun 30, 2020 | -522.53% |
| Mar 31, 2020 | -1,472.60% |
API Access
Abvc Biopharma EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();